bioRxivImmunology
Boosting of SARS-CoV-2 immunity in nonhuman primates using an oral rhabdoviral vaccine
K. W. Peng, T. Carey, P. Lech, R. Vandergaast, M. A. Munoz-Alia, N. Packiriswamy, C. Gnanadurai, K. Krotova, M. Tesfay, C. Ziegler, M. Haselton, K. Sevola, C. Lathrum, S. Reiter, R. Narjari, B. Balakrishnan, L. Suksanpaisan, T. Sakuma, J. Recker, L. Zhang, S. Waniger, L. Russell, C. Petro, C. A. Kyratsous, A. Baum, , S. J. Russell
Abstract
An orally active vaccine capable of boosting SARS-CoV-2 immune responses in previously infected or vaccinated individuals would help efforts to achieve and sustain herd immunity. Unlike mRNA-loaded lipid nanoparticles and recombinant replication-defective adenoviruses, replicating vesicular stomatitis viruses with SARS-CoV-2 spike glycoproteins (VSV-SARS2) were poorly immunogenic after intramuscular administration in clinical trials. Here, by G protein trans-complementation, we generated VSV-SARS2(+G) virions with expanded target cell tropism. Compared to parental VSV-SARS2, G-supplemented viruses were orally active in virus-naive and vaccine-primed cynomolgus macaques, powerfully boosting SARS-CoV-2 neutralizing antibody titers. Clinical testing of this oral VSV-SARS2(+G) vaccine is planned.
- organism: non-human primate
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Protective Efficacy of Gastrointestinal SARS-CoV-2 Delivery Against Intranasal and Intratracheal SARS-CoV-2 Challenge in Rhesus Macaques
J. Yu, N. Collins, … D. H. Barouch·bioRxiv·Sep 13, 2021
- One mucosal administration of a live attenuated recombinant COVID-19 vaccine protects non-human primates from SARS-CoV-2
M. F. Tioni, R. Jordan, … R. S. Tang·bioRxiv·Jul 16, 2021
- Immunogenicity of low dose prime-boost vaccination of mRNA vaccine CV07050101 in non-human primates
N. van Doremalen, R. Fischer, … V. Munster·bioRxiv·Jul 7, 2021
- A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques
A. O. Hassan, F. Feldmann, … M. S. Diamond·bioRxiv·Jan 26, 2021
- Prime-boost protein subunit vaccines against SARS-CoV-2 are highly immunogenic in mice and macaques
H.-X. Tan, J. A. Juno, … A. K. Wheatley·bioRxiv·Sep 1, 2020
- Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA SARS 2 S in preclinical vaccination
A. Tscherne, J. H. Schwarz, … A. Volz·bioRxiv·Jan 9, 2021